| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |